Something else to discuss while we wait for Monday's...

Something else to discuss while we wait for Monday's results...

Don't know if many actually read this article posted by @Sawvic as the link went nowhere. Couple of interesting pieces of information contained within it I thought:

"The market collapse has proved tantalising for investors such as Mr De Silva, who has persuaded entrepreneurs including Chris Behrenbruch, Patrick Davies, Glen Haifer and Lou Pannacio to tip money into the new fund which is called KP Rx. Dr Behrenbruch is the CEO of ASX listed Telix Pharmaceuticals which recently received TGA approval for its prostrate cancer drug. Patrick Davies is chairman of ASX listed Neuren which develops therapies for neurological issues. And Dr Haifer sold his bio analytical laboratory for around $300 million in 2021...

...While the team hopes to snap up deals in companies struggling to fund clinical trials, they will face stiff competition. Global pharmaceutical companies are flush with cash and in the past 12 months some mega deals have signalled the start of a consolidation period.
Earlier this year Pfizer bought Seagen for US $43 billion, and a month later Merck bought Prometheus for US $10 billion. Biogen bought Reata for US$6.7 billion, Novartis acquired Chinook for US$3.1 billion and Horizon bought Amgen for $27.8 billion."

Of course we are all familiar with Patrick Davies. Chris Behrenbruch has been mentioned in this forum as the possible author of a a very unsavoury blog post about Neuren when he was the editor of said blog some time ago (as I recall). Wonder if he has changed his tune yet and/or issued Patrick an apology if it comes up over tea and scones at KP Rx??

The deals mentioned at the end of the article have all been pointed out here by Piton and others but lumped together like that they do make one think that Neuren's timing may be impeccable if results go our way on Monday.